Electric leg stimulation aims to preserve bladder function in spinal injury patients

NCT ID NCT04350359

Completed Disease control Sponsor: The University of Texas Health Science Center, Houston Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study tests whether a non-invasive nerve stimulation on the leg, called transcutaneous tibial nerve stimulation (TTNS), can help maintain bladder function in people with recent spinal cord injury. Researchers will enroll 120 adults with spinal injuries at level T9 or above, starting treatment within 6 weeks of injury. The goal is to see if regular TTNS sessions can preserve bladder capacity and reduce bladder problems, potentially improving quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcutaneous tibial nerve stimulation (TTNS) device
What this could lead to: If it works, this could offer a non-invasive way to help people with spinal cord injury maintain bladder control and improve quality of life.
What could go wrong: This is an early-stage study with 120 participants, so results may not apply to everyone. The treatment may not work for all injury levels, and some people may find the stimulation uncomfortable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spinal cord injury Urinary Bladder, Neurogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPINAL CORD INJURIES

Contacts and locations

Locations

MedStar National Rehabilitation Hospital

Washington D.C., District of Columbia, 20010, United States
TIRR Memorial Hermann Research Center

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.